Molecular Infectious Disease Testing Market to Hit USD 17.78 Billion by 2029 with 13.7% CAGR | MarketsandMarkets™.
The global Molecular Infectious Disease Testing market, valued at US$8.49 billion in 2023, is forecasted to grow at a robust ...
Molecular Infectious Disease Testing Market to Hit USD 17.78 Billion by 2029 with 13.7% CAGR | MarketsandMarkets.
The global Molecular Infectious Disease Testing market, valued at US$8.49 billion in 2023, is forecasted to grow at a robust CAGR of 13.7%, ...
J.P. Morgan Sticks to Its Sell Rating for Roche Holding AG (RHHVF)
J.P. Morgan analyst Richard Vosser maintained a Sell rating on Roche Holding AG (RHHVF – Research Report) today and set a price target of ...
PharmiWeb2d
In Vitro Diagnostics Market Size to Expand USD 129.14 Bn by 2033
The global in vitro diagnostics market size was reached at USD 83.41 billion in 2024 and is expected to expand around USD 129.14 billion by 2033, with a CAGR of 4.97% from 2024 to 2033. The market is ...
PharmiWeb10d
FDA approves Roche’s Susvimo as the first and only continuous delivery treatment for the leading cause of diabetes-related blindness
Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the US Food and Drug Administration (FDA) has approved Susvimo® (ranibizumab injection) 100 mg/mL for the treatment of diabetic macular edema ...
J.P. Morgan Reaffirms Their Hold Rating on Bayer (0P6S)
J.P. Morgan analyst Richard Vosser maintained a Hold rating on Bayer (0P6S – Research Report) today and set a price target of €25.00. The ...
Ibj.com10d
Roche gets FDA clearance for test of emerging cardiovascular disease risk
Lipoprotein(a) has long been recognized as a critical marker for people at risk of cardiovascular disease. However, the health care industry has lacked the tools to tackle the problem.
Pharmabiz9d
Roche’s Susvimo receives US FDA approval for the treatment of diabetic macular edema
Roche’s Susvimo receives US FDA approval for the treatment of diabetic macular edema: Basel Thursday, February 6, 2025, 11:00 Hrs [IST] Roche announced that the US Food and Drug ...
Medical Xpress on MSN7d
Research Pinpoints Weakness in Lung Cancer’s Defenses
Researchers discovered the importance of an enzyme that promotes growth of certain lung cancers. Lung cancer is a ...
Yahoo Finance22d
Roche receives FDA clearance with CLIA waiver for cobas® liat molecular tests to diagnose sexually transmitted infections at the point of care
“Rapid molecular point-of-care testing can revolutionise ... said Matt Sause, CEO Roche Diagnostics.
Healio11d
FDA clears first assay designed to measure lipoprotein(a) in nanomoles
Roche announced its next generation assay received FDA 510(k) clearance for the measurement of lipoprotein(a) for assessment ...